Table 3 Patients’ angiographic and procedure characteristics of total studied patients, unlikely/possible FH, and probable/definite FH groups.
Variables | Total (n = 690) | Unlikely/possible FH (n = 594) | Probable/definite FH (n = 96) | P-value |
|---|---|---|---|---|
Infarcted-related artery | ||||
LAD | 413 (59.9) | 349 (58.8) | 64 (66.7) | 0.462 |
LCx | 98 (14.2) | 89 (15.0) | 9 (9.4) | |
RCA | 167 (24.2) | 144 (24.2) | 23 (24.0) | |
Ramus | 9 (1.3) | 9 (1.5) | 0 (0.0) | |
LM | 2 (0.3) | 2 (0.3) | 0 (0.0) | |
Not identified | 1 (0.1) | 1 (0.2) | 0 (0.0) | |
Number of diseased vessels | ||||
One vessel disease | 302 (43.8%) | 265 (44.6%) | 37 (38.5%) | 0.026 |
Two vessel disease | 256 (37.1%) | 225 (37.9%) | 31 (32.3%) | |
Three vessel disease | 132 (19.1%) | 104 (17.5%) | 28 (29.2%) | |
Syntax score | 19.53 ± 5.5 | 18.66 ± 4.9 | 24.91 ± 5.8 | < 0.001 |
Thrombus burden grade | ||||
0 | 54 (7.8%) | 47 (7.9%) | 7 (7.3%) | 0.024 |
1 | 174 (21.3%) | 133 (22.4%) | 15 (15.6%) | |
2 | 331 (48%) | 290 (48.8%) | 40 (41.7%) | |
3 | 84 (12.2%) | 68 (11.4%) | 16 (16.7%) | |
4 | 74 (10.7%) | 56 (9.4%) | 18 (18.8%) | |
High thrombus burden | 74 (10.7%) | 56 (9.4%) | 18 (18.8%) | 0.006 |
Thrombus aspiration device | 9 (1.3%) | 5 (0.8%) | 4 (4.2%) | 0.008 |
Number of used stents | 1.16 ± 0.5 | 1.17 ± 0.5 | 1.11 ± 0.6 | 0.354 |
Final TIMI flow grade | ||||
0 | 14 (2) | 11 (1.9) | 3 (3.1) | 0.035 |
I | 21 (3) | 16 (2.7) | 5 (5.2) | |
II | 71 (10.3) | 57 (9.6) | 14 (14.6) | |
III | 584 (84.6) | 510 (85.9) | 74 (77.1) | |
Final TIMI flow slow/no-reflow | 106 (15.4%) | 84 (14.1%) | 22 (22.9%) | 0.027 |
Glycoprotein IIb/IIIa inhibitors | 259 (37.5%) | 215 (36.2%) | 44 (45.8%) | 0.070 |
